The phrase GLP-1 probiotic can lead to products with different names, ingredients and intended marketing contexts. It can also draw a general digestive probiotic into a search that began with prescription treatment. A comparison needs to keep those distinctions visible before it compares numbers or repeats research claims.
CoreAge appears first through a commercial publishing choice. Pendulum GLP-1 Probiotic and US Culturelle Digestive Daily are the other two exact records considered here; Culturelle is sold as a digestive probiotic, not as a GLP-1-branded medicine or supplement. The study-match guide explains why this ordering is not a conclusion about clinical effectiveness.
Keep this distinction in view
Compare what each source actually declares before considering whether a study answers the question being asked.
Compare the same kind of information first
The most useful common fields are the exact product, the declared organisms, any strain identifiers, the unit attached to the quantity and the evidence being cited. NIH distinguishes genus, species and strain, and warns against treating results from different probiotic strains as interchangeable. That framework supports document reading; it does not produce a universal best product. The name guide works through the distinctions without requiring the reader to memorize taxonomy. The comparison is deliberately limited to public records available on the review date. It does not assess adherence, clinical care, delivered quality or anyone’s response to a capsule. A manufacturer’s broad research history also needs to be separated from a study of the preparation on sale now. Otherwise, a comparison can accidentally award a product credit for evidence that belongs to another strain, population or formula. NIH
CoreAge supplies a mass but not a strain-level count
The CoreAge offer lists a 36 mg blend containing B. infantis, C. butyricum and A. muciniphila, with chicory-root inulin 211 mg and potato resistant starch 100 mg. Strain codes, individual organism amounts and CFU or AFU counts are absent from the reviewed panel. That absence does not support a negative efficacy verdict, but it prevents a confident equivalence claim. The full CoreAge review also retains its purchase conflict: the six-bottle, 180-capsule, six-month option shows $149 total beside $23.83 per bottle. A reader should not have to assume which of those numbers the seller intended.
Pendulum supplies some additional identifiers, not every answer
The pictured Pendulum panel declares a combined 500 million AFU blend. It identifies C. butyricum WB-STR-0006 and A. muciniphila WB-STR-0001, while B. infantis has no visible code. Chicory inulin is 211 mg. The codes narrow part of the identification; they do not provide a separate count for each organism or turn AFU into CFU. The Pendulum review distinguishes its current retail formulation from a separate five-organism research preparation. The manufacturer’s survey claims concern reported cravings, not a controlled test of prescription GLP-1 adverse effects. More printed identifiers are useful information, but they are not themselves a clinical ranking.
Culturelle is a deliberately different comparator
The inspected US Digestive Daily panel prints Lactobacillus rhamnosus GG, 40 mg and 10 billion CFUs, alongside chicory-root-extract inulin 200 mg. NIH uses the updated genus name Lacticaseibacillus while connecting it to the older Lactobacillus name. The Culturelle review preserves the words on the actual panel and the exact thirty-capsule selection. It is included to show a named strain and a dual mass/count declaration in a general digestive product. That editorial purpose must not be converted into a claim that Culturelle was designed for, or established as beneficial in, all people using GLP-1 medicines. NIH nomenclature
The study question has to travel with the result
A twelve-week primary trial enrolled 76 people with type 2 diabetes and tested separate WBF preparations, including five-organism WBF-011. It was not a three-way trial of these retail products. Pendulum’s current product page separately reports a six-week consumer survey of 274 people. The evidence-design guide explains why a self-reported craving response and a glucose-related trial endpoint are different observations. Neither supports a claim that these products are equally effective, that one wins, or that all have been tested alongside every GLP-1 prescription. Even a well-described study remains bounded by its preparation, participants and measurements. Primary trial Survey record
Record commitments without calculating a potency bargain
CoreAge’s one-time bundles are $49 for one bottle/thirty capsules/one month, $99 for three/ninety/three months, and $149 for six/180/six months, with the stated per-bottle conflict retained. Pendulum’s variant record shows $64 for its one-month recurring option every thirty days, $173 for three months recurring every ninety days, and $89 for the separate one-time choice. Culturelle’s thirty-capsule variant shows $17.99 one-time or $16.19 per subscription order with thirty- or sixty-day choices. These are current product/order figures, not delivered all-in quotes or a cost per biological effect. Taxes, shipping and eligibility remain separate.
Unanswered details belong beside the comparison
CoreAge advertises optional discounted refills and shipping over $50; its return clocks conflict. Pendulum’s terms distinguish refunds from physical returns and impose guarantee and cancellation conditions. Culturelle advertises free subscription shipping, while its direct-site refund policy reserves approval. Those differences deserve the full context in each review, not a generic risk-free badge. The fixed source reader leaves the scientific limits open as well. A clinician or pharmacist can discuss the relevance of a proposed product to actual care; a seller can answer product and transaction questions. FDA’s supplement framework does not certify personal suitability, and no purchase should substitute for prescribed care. CoreAge terms Pendulum terms Culturelle policy FDA
Sources for this article
NIH Office of Dietary Supplements: Probiotics, Health Professional Fact Sheet
Federal evidence review for organism nomenclature, strain-specific clinical context, mechanisms and quantities; no product or patient clearance
Checked 2026-09-28
https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/CoreAge Rx: GLP-1 Support current offer and online Supplement Facts
Fresh seller formula and full offer record; inspected bottle front only, no physical back panel, lot assay or transaction verification
Checked 2026-09-28
https://try.coreagerx.com/glp-supp-spPendulum: GLP-1 Probiotic current product and facts image
Fresh product record and actually inspected current pictured panel; two visible strain codes, combined AFU declaration and attributed six-week consumer survey, not a supplied-lot test
Checked 2026-09-28
https://pendulumlife.com/products/glp-1-probiotic-for-cravingsCulturelle: US Digestive Daily Probiotic Capsules
Fresh exact US product page plus two inspected official facts images; general digestive product, not GLP-1-specific branding or universal clinical indication
Checked 2026-09-28
https://culturelle.com/products/digestive-daily-probioticBMJ Open Diabetes Research & Care: Improvements to postprandial glucose control in subjects with type 2 diabetes, 2020
Full primary twelve-week randomized three-arm proof-of-concept study, 76 participants; WBF-011 five-organism preparation and glucose outcomes are not current three-organism retail GLP-1 formula results
Checked 2026-09-28
https://drc.bmj.com/content/8/1/e001319Pendulum: public GLP-1 Probiotic variant and selling-plan record
Fresh public structured response; exact one-month, three-month and one-time USD selections, no cart/stock/charge authentication
Checked 2026-09-28
https://pendulumlife.com/products/glp-1-probiotic-for-cravings.jsCulturelle: public Digestive Daily variant and selling-plan record
Fresh public structured response; selected US thirty-capsule variant 39930481082446 and its recurring allocations, no checkout verification
Checked 2026-09-28
https://culturelle.com/products/digestive-daily-probiotic.jsCoreAge Rx: Refund, Return, Subscription & Shipping Policy
Current seller policy; nonprescription eligibility and delivery clock kept separate from broad purchase-date cutoff and prescription provisions
Checked 2026-09-28
https://www.coreagerx.com/returns-refund-policy/Pendulum: Terms and Conditions, revised February 11, 2026
Fresh TinyFish primary text; exact GLP-1 Probiotic first-purchase guarantee, physical-return limit and Sunday cancellation cutoff, not clinical use advice
Checked 2026-09-28
https://pendulumlife.com/pages/terms-and-conditionsCulturelle: Refund and Return Policy
Official-page web-index fallback retrieved September 28, 2026 and reported crawled two weeks earlier after direct/TinyFish failures; direct-purchase eligibility, shipping exclusion and reserved approval, no tested refund
Checked 2026-09-28
https://culturelle.com/pages/refund-and-return-policyFDA: Information for Consumers on Using Dietary Supplements
Primary regulator supplement overview; no product approval, legal compliance verdict or individual eligibility
Checked 2026-09-28
https://www.fda.gov/food/dietary-supplements/information-consumers-using-dietary-supplements